Full text is available at the source.
Abstract
Electroporation-based delivery of Cas9 protein achieves high efficiency in difficult-to-transfect human cancer cell lines and primary cells.
- CRISPR/Cas9 is a widely used tool for genome editing in many human cancer cell lines.
- Gene editing remains challenging in certain hard-to-transfect cell lines and primary cells.
- An electroporation-based method has been developed to improve the delivery of Cas9 protein.
- This method utilizes chemically modified sgRNAs for enhanced performance.
- The protocol demonstrates significant efficiency across various cell lines and primary cells.
Simplified